Low-dose galactose rebalances HBP-mTORC1-SREBP-1c signaling …

Emerging


0
Citations
42
Refs
2026
Year
Search Works
Work Details
  • DOI 10.1152/ajpgi.00379.2025
  • PMID https://pubmed.ncbi.nlm.nih.gov/41528029
  • OpenAlex ID W7123894905
  • Type Article
  • Language EN
  • Published 13 Jan 2026
  • Volume 330 (2)
  • Pages G170–G188
  • Source American Journal of Physiology-Gastroint…
  • Publisher American Physiological Society
  • Countries 1
  • Institutions 1
  • Added 14 Jan 2026
  • Updated 16 Oct 2026
MENU
0

Low-dose galactose rebalances HBP-mTORC1-SREBP-1c signaling to suppress hepatic lipogenesis and protect against early-stage alcohol-related liver disease

Article 2026 EN Hybrid

This study demonstrates that low-dose galactose, a dairy-derived monosaccharide, regulates hepatic de novo lipogenesis (DNL) by selectively inhibiting glucose-induced DNL activation. Mechanistically, low-dose galactose suppresses hexosamine biosynthetic pathway (HBP) flux, protein O-GlcNAcylation, and mTORC1 signaling, thereby inhibiting SREBP-1c activation in a Leloir pathway-dependent manner. No…

0

Citations

42

References

7

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
7 authors
#AuthorInstitutionsORCID
1 Yanhui Li Corresponding University of Illinois Chicago (US)
2 Rui Guo Corresponding University of Illinois Chicago (US) —
3 Yanyu Qian University of Illinois Chicago (US) —
4 Izabela Hawro University of Illinois Chicago (US)
5 José Córdoba‐Chacón University of Illinois Chicago (US)
6 Yuwei Jiang University of Illinois Chicago (US)
7 Zhenyuan Song University of Illinois Chicago (US)

Data: OpenAlex